Perfluorochemical Emulsions Can Increase Tumor Radiosensitivity-Reference-Cited by-同舟云学术

Perfluorochemical Emulsions Can Increase Tumor Radiosensitivity

Published:1984-03-02 Issue:4639 Volume:223 Page:934-936
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Teicher Beverly A.¹,Rose Christopher M.¹

Affiliation:

1. Dana-Farber Cancer Institute, Boston, Massachusetts 02115, and Department of Radiation Therapy, St. Joseph Medical Center, Burbank, California 91505

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference46 articles.

1. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 1982 8 3/4

2. ADAMSON, E.D., CONTROL OF EARLY DEVELOPMENT, BRITISH MEDICAL BULLETIN 35: 113 (1979).

3. BROWN, J.M., PARTITION-COEFFICIENT AS A GUIDE TO THE DEVELOPMENT OF RADIOSENSITIZERS WHICH ARE LESS TOXIC THAN MISONIDAZOLE, RADIATION RESEARCH 82: 171 (1980).

4. CLEMENT, J.J., ENHANCEMENT OF ANTI-TUMOR ACTIVITY OF ALKYLATING-AGENTS BY THE RADIATION SENSITIZER MISONIDAZOLE, CANCER RESEARCH 40: 4165 (1980).

5. DENEKAMP, J, RADIOPROTECTION OF MOUSE SKIN BY WR-2721 - THE CRITICAL INFLUENCE OF OXYGEN-TENSION, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 8: 531 (1982).

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomimetic mineralization: construction and biomedical applications of biohybrid materials;Materials Chemistry Frontiers;2024

2. Hypoxia signaling in cancer: Implications for therapeutic interventions;MedComm;2023-01-23

3. An all-in-one nanoplatform with near-infrared light promoted on-demand oxygen release and deep intratumoral penetration for synergistic photothermal/photodynamic therapy;Journal of Colloid and Interface Science;2022-02

4. Recent advances in in situ oxygen-generating and oxygen-replenishing strategies for hypoxic-enhanced photodynamic therapy;Biomaterials Science;2022

5. Perfluorocarbons Therapeutics in Modern Cancer Nanotechnology for Hypoxiainduced Anti-tumor Therapy;Current Pharmaceutical Design;2021-12